Bristol Myers Squibb is committed to helping appropriate patients get access to our
medications by providing access and reimbursement support services.

This information is intended for U.S. healthcare professionals and/or healthcare professionals involved in healthcare reimbursement.

Billing and
Diagnosis Codes

Reimbursement and Coding Guide for OPDIVO
Download

The information below is designed to help appropriate patients get access to OPDIVO by providing helpful reimbursement information for healthcare offices. It is important that offices verify each patient’s insurance coverage prior to initiating therapy. BMS Access Support may be able to help.


Metastatic Melanoma

Unresectable or Metastatic Melanoma (mMelanoma) Monotherapy

View Codes >

Unresectable or Metastatic Melanoma (mMelanoma) Combination Therapy

View Codes >

Adjuvant Treatment of Melanoma (Adj Tx of Melanoma) Monotherapy

View Codes >


Non-Small Cell Lung Cancer

Metastatic Non-Small Cell Lung Cancer (mNSCLC) Monotherapy

View Codes >

Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer (NeoAdj Tx of NSCLC) and Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Combination Therapy

View Codes >


Malignant Pleural Mesothelioma

Unresectable Malignant Pleural Mesothelioma (MPM) Combination Therapy

View Codes >


Advanced Renal Cell Carcinoma

Advanced Renal Cell Carcinoma (aRCC) Monotherapy

View Codes >

Advanced Renal Cell Carcinoma (aRCC)
Combination Therapy

View Codes >


Classical Hodgkin Lymphoma

Classical Hodgkin Lymphoma (cHL) Monotherapy
 

View Codes >


Recurrent or Metastatic Squamous Cell Carcinoma
of the Head and Neck

Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) Monotherapy

View Codes >


Urothelial Carcinoma

Locally Advanced or Metastatic Urothelial Carcinoma (UC) Monotherapy

View Codes >

Adjuvant Treatment of Urothelial Carcinoma (UC) Monotherapy

View Codes >


Metastatic Colorectal Cancer

Metastatic Colorectal Cancer (mCRC) Monotherapy
 

View Codes >

Metastatic Colorectal Cancer (mCRC)
Combination Therapy

View Codes >


Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)
Combination Therapy

View Codes >


Gastroesophageal Cancer

Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) Monotherapy

View Codes >

Adjuvant Treatment of Resected Esophageal or Gastroesophageal Junction Cancer

View Codes >

Advanced or Metastatic Gastric or Gastroesophageal Junction or Esophageal Adenocarcinoma

View Codes >

Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) Combination Therapy

View Codes >


The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Support Center icon
Support Center: 1-800-861-0048
am to 8 pm ET, Mon - Fri
Schedule a Call icon
Schedule a call from a Patient Access SpecialistSchedule a Call >
Request a Visit icon
Request a visit from a BMS Access & Reimbursement ManagerRequest a Visit >
Schedule a Call Request a Visit

BMS Logo

©2022 Bristol-Myers Squibb Company. All rights reserved. Access Support is a registered trademark of Bristol-Myers Squibb Company.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Statement. The coding, coverage, and payment information contained within this website is current as of 03/22.

1506-US-2101816 03/22